itraconazole has been researched along with Communicable Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottero, J; Fournier, S; Gallien, S; Molina, JM; Porcher, R; Ribaud, P; Socié, G; Sulahian, A | 1 |
| Brunet, J; Cancelas, JA; López-López, JJ; Maroto, P; Mendoza, L; Montesinos, J; Ojeda, B; Rodríguez, M; Salazar, R; Solá, C; Tabernero, JM; Valentí, V; Verger, G | 1 |
1 review(s) available for itraconazole and Communicable Diseases
| Article | Year |
|---|---|
Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Communicable Diseases; Female; Hospital Units; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Paris; Prognosis; Risk Factors; Treatment Outcome; Young Adult | 2008 |
1 other study(ies) available for itraconazole and Communicable Diseases
| Article | Year |
|---|---|
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Ciprofloxacin; Combined Modality Therapy; Communicable Diseases; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Itraconazole; Male; Middle Aged; Neoplasms; Prospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Transplantation, Autologous; Treatment Outcome | 1999 |